Dietary Intake of Omega-3 Fatty Acids and Endocrine-Related Gynecological Cancer: A Meta-Analysis of Observational Studies
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose Previous observational epidemiological studies have reported inconsistent findings on the association between dietary intake of omega-3 fatty acids and endocrine-related gynecological cancer such as ovarian cancer and endometrial cancer. This study aimed to investigate this association using a meta-analysis of observational studies. Materials and Methods We searched PubMed, EMBASE, and Cochrane library by using key words related with the topic in April 2017. The pooled odds ratios (pORs), pooled relative risks, or pooled hazard ratios (pHRs) with 95% confidence intervals (CIs) were calculated based on the randomeffects model. Also, we performed subgroup meta-analysis by methodological quality, types of cancer, study design, and omega-3 fatty acids. Results A total of 10 observational studies with six case-control and four cohort studies were included in the final meta-analysis. In the meta-analysis of all the studies, dietary intake of total omega-3 fatty acids was not significantly associated with the risk of endometrial and ovarian cancers (pOR/hazard ratio, 0.87; 95% CI, 0.73 to 1.04; I2=67.2%) (highest vs. lowest intake). In the subgroup meta-analysis by type of study, there was no significant association between them in cohort studies (pHR, 1.03; 95% CI, 0.63 to 1.67; I2=81.9%), whereas its reduced risk was observed in case-control studies (pOR, 0.81; 95% CI, 0.67 to 0.98; I2=55.7%). Conclusion The current meta-analysis of observational studies suggests that there is no higher level of evidence to support the protective effect of dietary omega-3 fatty acids on endocrine-related gynecological cancer. Further prospective studies should be conducted to confirm the association.
Abstract
Purpose Previous observational epidemiological studies have reported inconsistent findings on the association between dietary intake of omega-3 fatty acids and endocrine-related gynecological cancer such as ovarian cancer and endometrial cancer. This study aimed to investigate this association using a meta-analysis of observational studies. Materials and Methods We searched PubMed, EMBASE, and Cochrane library by using key words related with the topic in April 2017. The pooled odds ratios (pORs), pooled relative risks, or pooled hazard ratios (pHRs) with 95% confidence intervals (CIs) were calculated based on the randomeffects model. Also, we performed subgroup meta-analysis by methodological quality, types of cancer, study design, and omega-3 fatty acids. Results A total of 10 observational studies with six case-control and four cohort studies were included in the final meta-analysis. In the meta-analysis of all the studies, dietary intake of total omega-3 fatty acids was not significantly associated with the risk of endometrial and ovarian cancers (pOR/hazard ratio, 0.87; 95% CI, 0.73 to 1.04; I2=67.2%) (highest vs. lowest intake). In the subgroup meta-analysis by type of study, there was no significant association between them in cohort studies (pHR, 1.03; 95% CI, 0.63 to 1.67; I2=81.9%), whereas its reduced risk was observed in case-control studies (pOR, 0.81; 95% CI, 0.67 to 0.98; I2=55.7%). Conclusion The current meta-analysis of observational studies suggests that there is no higher level of evidence to support the protective effect of dietary omega-3 fatty acids on endocrine-related gynecological cancer. Further prospective studies should be conducted to confirm the association.
참고문헌 (36)
- Felix AS, "Factors associated with type I and type II endometrial cancer", Cancer Causes Control, 21, pp.1851~1856 (2010)
- Gibson DA, "Evidence of androgen action in endometrial and ovarian cancers", Endocr Relat Cancer, 21, pp.T203~T218 (2014)
- Dossus L, "Obesity, inflammatory markers, and endometrial cancer risk : a prospective case-control study", Endocr Relat Cancer, 17, pp.1007~1019 (2010)
- Wang T, "A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers", Cancer Epidemiol Biomarkers Prev, 20, pp.971~977 (2011)
- McSorley MA, "C-reactive protein concentrations and subsequent ovarian cancer risk", Obstet Gynecol, 109, pp.933~941 (2007)
- Verdoodt F, "Nonsteroidal anti-inflammatory drug use and risk of endometrial cancer : a systematic review and meta-analysis of observational studies", Gynecol Oncol, 140, pp.352~358 (2016)
- Murphy MA, "Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review", Cancer Causes Control, 23, pp.1839~1852 (2012)
- Kantor ED, "Association between use of specialty dietary supplements and C-reactive protein concentrations", Am J Epidemiol, 176, pp.1002~1013 (2012)
- Micallef MA, "An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals", Eur J Clin Nutr, 63, pp.1154~1156 (2009)
- Ebrahimi M, "Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity", Acta Cardiol, 64, pp.321~327 (2009)
- Malekshahi Moghadam A, "Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients", Singapore Med J, 53, pp.615~619 (2012)
- Micallef MA, "Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals", Atherosclerosis, 204, pp.476~482 (2009)
- Bertone ER, "Dietary fat intake and ovarian cancer in a cohort of US women", Am J Epidemiol, 156, pp.22~31 (2002)
- Bidoli E, "Nutrient intake and ovarian cancer : an Italian casecontrol study", Cancer Causes Control, 13, pp.255~261 (2002)
- Tavani A, "n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland", Int J Cancer, 105, pp.113~116 (2003)
- Lucenteforte E, "Macronutrients, fatty acids and cholesterol intake and endometrial cancer", Ann Oncol, 19, pp.168~172 (2008)
- Ibiebele TI, "Intake of omega-3and omega-6 fatty acids and risk of ovarian cancer", Cancer Causes Control, 23, pp.1775~1783 (2012)
- Brasky TM, "Associations of long-chain omega-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort", Am J Clin Nutr, 99, pp.599~608 (2014)
- Merritt MA, "Dietary fat intake and risk of epithelial ovarian cancer by tumour histology", Br J Cancer, 110, pp.1392~1401 (2014)
- Brasky TM, "Long-chain omega-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative", Am J Clin Nutr, 101, pp.824~834 (2015)
- Brasky TM, "Associations of dietary long-chain omega-3 polyunsaturated fatty acids and fish consumption with endometrial cancer risk in the Black women's health study", Am J Epidemiol, 183, pp.199~209 (2016)
- Arem H, "Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case-control study", Eur J Nutr, 52, pp.1251~1260 (2013)
- "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses" (2000)[URL]
- Higgins JP, "Quantifying heterogeneity in a meta-analysis", Stat Med, 21, pp.1539~1558 (2002)
- "Cochrane handbook for systematic reviews of interventions" (2011)[URL]
- Borenstein M, "A basic introduction to fixed-effect and random-effects models for meta-analysis", Res Synth Methods, 1, pp.97~111 (2010)
- 최윤정, "Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies", Cancer Research and Treatment, 50(2), pp.474~487 (2018), 대한암학회
- Macaskill P, "A comparison of methods to detect publication bias in meta-analysis", Stat Med, 20, pp.641~654 (2001)
- Hammer GP, "Avoiding bias in observational studies : part 8 in a series of articles on evaluation of scientific publications", Dtsch Arztebl Int, 106, pp.664~668 (2009)
- Giovannucci E, "A comparison of prospective and retrospective assessments of diet in the study of breast cancer", Am J Epidemiol, 137, pp.502~511 (1993)
- Qiu W, "Dietary fat intake and ovarian cancer risk : a meta-analysis of epidemiological studies", Oncotarget, 7, pp.37390~37406 (2016)
- Zhao J, "Dietary fat intake and endometrial cancer risk: a dose response metaanalysis", Medicine (Baltimore), 95, pp.e4121~ (2016)
- Chapkin RS, "Dietary docosahexaenoic and eicosapentaenoic acid : emerging mediators of inflammation", Prostaglandins Leukot Essent Fatty Acids, 81, pp.187~191 (2009)
- Zheng H, "Inhibition of endometrial cancer by n-3 polyunsaturated fatty acids in preclinical models", Cancer Prev Res(Phila), 7, pp.824~834 (2014)
- Sharma A, "The effects of omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines", Gynecol Oncol, 99, pp.58~64 (2005)
- Wan XH, "Docosahexaenoic acid induces growth suppression on epithelial ovarian cancer cells more effectively than eicosapentaenoic acid", Nutr Cancer, 68, pp.320~327 (2016)
